JP Morgan Chase’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.99K Buy
+187
New +$4.9K ﹤0.01% 6954
2025
Q4
Sell
-64
Closed -$554 7442
2025
Q3
$554 Buy
64
+13
+25% +$93 ﹤0.01% 7043
2025
Q2
$161 Sell
51
-69
-58% -$214 ﹤0.01% 6798
2025
Q1
$504 Hold
120
﹤0.01% 6704
2024
Q4
$810 Hold
120
﹤0.01% 6755
2024
Q3
$392 Hold
120
﹤0.01% 6824
2024
Q2
$755 Hold
120
﹤0.01% 6646
2024
Q1
$876 Buy
+120
New +$1K ﹤0.01% 6657
2023
Q4
Sell
-22
Closed -$210 7534
2023
Q3
$210 Hold
22
﹤0.01% 6837
2023
Q2
$486 Buy
+22
New +$584 ﹤0.01% 6550
2021
Q4
Sell
-8,506
Closed -$1.52M 6647
2021
Q3
$1.52M Sell
8,506
-12,399
-59% -$2.76M ﹤0.01% 3988
2021
Q2
$6.16M Buy
20,905
+5,865
+39% +$1.74M ﹤0.01% 2865
2021
Q1
$4.05M Sell
15,040
-8,099
-35% -$2.47M ﹤0.01% 3155
2020
Q4
$5.35M Buy
23,139
+9,858
+74% +$2.65M ﹤0.01% 2757
2020
Q3
$3.22M Sell
13,281
-36,005
-73% -$8.53M ﹤0.01% 2906
2020
Q2
$13.3M Buy
+49,286
New +$13.5M ﹤0.01% 1681

Other funds holding BNR

JP Morgan Chase's BNR Position: Q1 2026 in Review

JP Morgan Chase opened a new position in Burning Rock Biotech (BNR) in Q1 2026: 187 shares worth $2.99K. The stake represents ﹤0.01% of the portfolio and ranks #6954 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in BNR as recently as Q3 2025.

JP Morgan Chase first reported a position in BNR in Q2 2020 and has held it in 16 quarters since. The position peaked at $13.3M in Q2 2020. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • JP Morgan Chase held 187 shares of Burning Rock Biotech worth $2.99K as of Q1 2026.
  • Burning Rock Biotech was a new JP Morgan Chase position in Q1 2026.
  • Burning Rock Biotech made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6954 holding.
  • JP Morgan Chase first reported a position in Burning Rock Biotech in Q2 2020 and has held it in 16 quarters since.
  • JP Morgan Chase's Burning Rock Biotech position peaked at $13.3M in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.